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Excessive fatty acids and sugars intake is known to affect the development of cardiovascular diseases, including myocardial
infarction. However, the underlying mechanisms are ill defined. Here we investigated the balance between prosurvival and
detrimental pathways within the heart of C57Bl/6 male mice fed a standard diet (SD) or a high-fat high-fructose diet (HFHF)
for 12 weeks and exposed to cardiac ex vivo ischemia/reperfusion (IR) injury. Dietary manipulation evokes a maladaptive response
in heart mice, as demonstrated by the shift of myosin heavy chain isoform content from 𝛼 to 𝛽, the increased expression of the
Nlrp3 inflammasome andmarkers of oxidative metabolism, and the downregulation of the hypoxia inducible factor- (HIF-)2𝛼 and
members of the Reperfusion Injury SalvageKinases (RISK) pathway.When exposed to IR,HFHFmice hearts showed greater infarct
size and lactic dehydrogenase release in comparisonwith SDmice.These effects were associatedwith an exacerbated overexpression
of Nlrp3 inflammasome, resulting in marked caspase-1 activation and a compromised activation of the cardioprotective RISK/HIF-
2𝛼 pathways.The commonmechanisms of damage here reported lead to a better understanding of the cross-talk among prosurvival
and detrimental pathways leading to the development of cardiovascular disorders associated with metabolic diseases.
1. Introduction
Cardiovascular disorders associated with metabolic diseases
are referred to as cardiometabolic diseases (CMDs). Despite
the recent publication of several documents and papers
suggesting clinical and social interventions to prevent CMDs
and benefit subjects afflicted with these comorbidities, the
identification of common mechanisms of disease is far from
clear. A growing body of evidences indicates that excessive
fatty acids and sugars intake affects the development and
progression of cardiovascular diseases, including myocardial
infarction, by increasing the local inflammatory response
and, at the same time, by reducing the efficiency of protective
responses that are usually activated by transient oxygen
deprivation [1–3]. However, the underlying mechanisms
leading to these impairments are complex, and a more
thorough understanding is needed.
When exposed to an ischemic insult the cardiomyocytes
easily switch from fatty acid (FA) oxidation towards glycolytic
metabolism and increase glucose uptake to sustain ATP
generation and support cardiac function. The loss of this
metabolic flexibility is themain feature of amaladapted heart.
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For instance, mice with diet-induced obesity and exposed
to daily repetitive brief-duration cardiac ischemia exhibited
an early and profound downregulation of myocardial genes
involved in FA oxidation, such as muscle-type carnitine
palmitoyltransferase 1 (CPT-1m) and medium-chain acyl-
coenzyme A dehydrogenase with respect to lean mice [2].
Besides, an excessive FA oxidation has been demonstrated to
contribute to cardiac dysfunction in obesity and diabetes [4].
One of the most recently identified proinflammatory
signaling pathways involved in CMDs is the NOD-like
receptor pyrin domain containing 3 (Nlrp3) inflammasome,
a large multimeric protein complex mediating the cleavage of
inactive prointerleukin- (IL-) 1𝛽 and IL-18 into their active
form [5]. We and others have recently demonstrated that
activation of Nlrp3 inflammasome contributes to the devel-
opment of heart failure and diet-induced renal dysfunction
[6, 7], mainly by inducing IL-1𝛽 and IL-18 overproduction.
These cytokines of the IL-1 family modulate the insulin-
producing pancreatic𝛽-cell function and act as inflammatory
mediators in myocardial ischemia/reperfusion (IR) injury
[8, 9]. Reactive oxygen species (ROS), which are produced
during IR, may activate Nlrp3 inflammasome and all known
Nlrp3 inflammasome activators generate ROS whereas ROS
inhibitors block Nlrp3 inflammasome activation [10–12].
The ischemic injury may also evoke the transient activa-
tion of prosurvival signaling pathways and several studies
demonstrate that the adaptations to hypoxic conditions are
regulated by the relative activities of molecules such as Akt,
extracellular-signal-regulated kinases (ERK), and glycogen
synthase kinase- (GSK-) 3𝛽 that taken together constitute
the so-called Reperfusion Injury Salvage Kinases (RISK)
pathway [13, 14]. The activation of the RISK pathway confers
cardioprotection against IR injury by avoiding the opening of
themitochondrial permeability transition pore at the onset of
reperfusion [15]. Interestingly, this prosurvival RISK pathway
signaling is less effective in animal models of obesity and
insulin resistance [16]. For instance, hearts from mice fed
a high-fat diet for 32 weeks showed compromised basal
expression and activation of the prosurvival RISK pathway
signaling compared to mice under normal diet [3].
Other protective pathways include the family of proteins
that coordinates at the transcriptional level the cellular
response to oxygen availability, mainly the hypoxia inducible
factor- (HIF-) 𝛼 [17]. HIF-1 and HIF-2 proteins are both
increased in the peri-infarct area after myocardial infarction
in rats and humans, and their powerful protection seems
to implicate mechanisms modulating glucose uptake and
utilization and preserving mitochondrial function [18–21].
HIF-2𝛼 expression occurs in remote areas from the infarct
[18] and it is necessary to maintain normal lipid homeostasis,
as constitutive HIF-2 activation in hepatocytes results in
impaired fatty acid beta-oxidation, decreased lipogenic gene
expression, and increased lipid storage capacity [22]. These
data suggest a broader role forHIF-2𝛼 in the pathophysiology
of several CMDs, including ischemic heart diseases.
Nevertheless, none of the above mentioned studies inves-
tigated the direct impact of dysmetabolic conditions (i.e.,
diet-induced insulin resistance) on the potential cross-talk
among these different prosurvival and detrimental signaling
pathways involved in ischemicmyocardial dysfunction.Thus,
we investigated the effects of an obesogenic/diabetogenic
high-fat high-fructose (HFHF) diet on cardiac tolerance to
IR challenging in mice and we validated the relevance of
impaired pivotal intracellular mechanisms, in the heart, a key
target organ of CMDs.
2. Materials and Methods
2.1. Animals and Dietary Manipulation. Male C57Bl/6j mice
(Charles River Laboratories, Calco, LC, Italy) aged 4 weeks
were randomly allocated into the following dietary regimens:
a standard low-sugars low-fat diet (Control, 𝑛 = 12) and
a high-fat high-fructose diet (HFHF, 𝑛 = 12), for twelve
weeks. Standard diet (D12450K, Research Diet Inc., New
Brunswick, NJ, USA) composition was as follows: 70% of
calories in carbohydrates (55% from corn starch and 15%
from maltodextrin), 10% of calories in fat (5% from soybean,
5% from butter). High-fat high-fructose diet (D03012907,
Research Diet Inc.) composition was as follows: 35% of
calories in carbohydrates (10% from maltodextrin and 25%
from fructose), 45% of calories in fat (5% from soybean, 40%
from lard). All groups received drink and food ad libitum.
The animal protocols followed in this study were
approved by the local “animal use and care committee” and
were in accordance with the European Directive 2010/63/EU
on the protection of animals used for scientific purposes. All
groups received drink and food ad libitum.
2.2. General Parameters. Body weight and food intake were
recorded weekly. Fasting glycemia was measured at the start
of the protocol and every 4weeks by saphenous vein puncture
using a glucometer (GlucoGmeter, Menarini Diagnostics,
Firenze, Italy).
Systolic blood pressure and pulse rate were assessed at
11 weeks of dietary manipulation as the mean value of 10
consecutive measurements obtained in the morning using a
tail-cuff sphygmomanometer (IITC; Life Sciences,Woodland
Hills, CA).
2.3. Ex Vivo Ischemia/Reperfusion (IR) Injury. After 12 weeks
of dietary manipulation, Control and HFHF mice were
pretreated with 500U heparin and anesthetized with sodium
pentothal (50mg/kg) by intraperitoneal injections before
being culled by cervical dislocation. Hearts were rapidly
excised, blood was rapidly collected from the thorax cavity,
and plasma was isolated. The excised heart was rapidly per-
fused at 80mmHg by the Langendorff technique with Krebs-
Henseleit bicarbonate buffer containing (mM) NaCl 118,
NaHCO
3
25, KCl 4.7, KH
2
PO
4
1.2,MgSO
4
1.2, CaCl
2
1.25, and
glucose 11. The buffer was gassed with 95% O
2
: 5% CO
2
. The
temperature of the perfusion system was maintained at 37∘C.
After a 30 min stabilization period, hearts were subjected
to a protocol of IR, which consisted in 30 min of global no-
flow, normothermic ischemia followed by a period of 60 min
of reperfusion for hearts of both groups (IR Control and IR
HFHF).Hearts ofControl andHFHFmice, after stabilization,
underwent 90min perfusion only (Sham Control and Sham
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HFHF) and served as reference groups in western blot
analysis (see the following).
The perfusate flowing out of the heart was collected and
measured. Collected coronary effluent was used for measure-
ment of lactate dehydrogenase (LDH) release. To assess the
conditions of experimental preparation the coronary flow
rate was determined by the amount of perfusate measured in
a specific time period.
At the end of perfusion period, the heart was rapidly
removed from the perfusion apparatus and divided into two
parts by a coronal section (perpendicular to the long axis);
while the apical part (less than 1/3 of ventricular mass) was
frozen rapidly in liquid nitrogen and stored at −80∘C and
subsequently used for western blot and histological analysis,
the basal part of ventricle was used for infarct size assessment.
2.4. Infarct Size Assessment. Infarct areas were assessed at the
end of the experiments with the nitroblue tetrazolium (NBT)
technique [23]. The basal part of the ventricles was dissected
by transverse sections into two-three slices. Following 20min
of incubation at 37∘C in 0.1% solution NBT (Sigma-Aldrich,
St. Louis, MO, USA) in phosphate buffer, unstained necrotic
tissue was carefully separated from stained viable tissue by
an independent observer, who was unaware of the protocols.
Since the ischemia was global and since we analyzed only the
basal part of the ventricles, the necrotic mass was expressed
as a percentage of the analyzed ischemic tissue (% of infarct
size on ischemic tissue, %IS/IT).
2.5. Detection of Lactate Dehydrogenase (LDH) Release. The
perfusion effluent was collected for 5min immediately before
ischemia and for the entire reperfusion period. LDH released
from the heart was determined by spectrophotometric anal-
ysis at 340 nm [23].
2.6. Biochemical Parameters. Plasma lipid profile was deter-
mined by standard enzymatic procedures using reagent kits
(triglycerides (TG), cholesterol, and high-density lipopro-
teins (HDL); Hospitex Diagnostics, Florence, Italy). Low-
density lipoproteins (LDL) were calculated by the formula:
total cholesterol − [HDL + (TG/5)]. Plasma insulin level
wasmeasured using an enzyme-linked immunosorbent assay
(ELISA) kit (Mercodia AB, Uppsala, Sweden).
2.7. Oil Red Staining. Cardiac intramyocellular lipid accu-
mulation was evaluated by Oil Red staining on 10𝜇m apex
cryostatic sections. Stained tissues were viewed under an
Olympus Bx4I microscope (40x magnification) with an
AxioCamMR5 photographic attachment (Zeiss, Gottingen,
Germany).
2.8. Immunohistochemistry. GLUT-4 expressionwas assessed
on 10 𝜇m apex cryostatic sections by immunohistochem-
istry. Endogenous peroxidases were inactivated by incubating
sections for 5min with 0.3% H
2
O
2
. Sections were then
blocked for 1 h with 3% BSA in PBS. Thus, sections were
incubated overnight with rabbit anti-GLUT-4 primary anti-
body (Abcam, Cambridge, UK) followed by HRP-conjugated
secondary antibodies. Sections were digitised with a high
resolution camera (Zeiss) at 20x magnification.
2.9. Western Blot Analysis. Total proteins extracts were
obtained from 10% (w/v) apex homogenates in RIPA buffer
(0.5% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS,
10mmol/L EDTA, and protease inhibitors). Protein content
was determined using the Bradford assay. Protein extracts
were stored at −80∘C until use. Equal amounts of pro-
teins were separated by SDS-PAGE and electrotransferred
to nitrocellulose membrane. Membranes were probed with
goat anti-𝛼-myosin heavy chain (𝛼-MHC), goat anti-𝛽-
MHC, rabbit anti-carnitine palmitoyltransferase (CPT) 1m,
mouse anti-succinate dehydrogenase (SDH), anti-glucose
transport- (GLUT-) 4 primary antibody (Abcam, Cambridge,
UK), rabbit anti-phospho-insulin receptor 2 (IRS2Ser270), and
mouse anti-IRS-2 (Cell Signaling, Danvers,MA,USA), rabbit
anti-Nlrp3 (Epitomics, Burlingame, CA, USA), rabbit anti-
caspase-1, rabbit anti-pERK1/2, rabbit anti-ERK, rabbit anti-
pAktSer473, rabbit anti-Akt, rabbit anti-pGSK-3𝛽Ser9, rabbit
anti-GSK-3𝛽, mouse anti-hypoxia inducible factor- (HIF-)
2𝛼, and goat anti-hydroxynonenal (HNE) (Novus Biologicals,
Abingdon, UK) primary antibodies, followed by incubation
with appropriated HRP-conjugated secondary antibodies
(Bio-Rad Laboratories, Hercules, CA, USA). Proteins were
detected with ECL detection system (ECL Clarity, Bio-Rad
Laboratories, Hercules, CA, USA) and quantified by den-
sitometry using analytic software (Quantity-One, Bio-Rad
Laboratories, Hercules, CA, USA). Results were normalized
with respect to 𝛼-tubulin densitometric value.
2.10. Materials. Unless otherwise stated, all compounds were
purchased from the Sigma-Aldrich Company Ltd. (St. Louis,
Missouri, USA). Antibodies were from Santa Cruz Biotech-
nology (Santa Cruz, CA, USA).
2.11. Statistical Analysis. All values are expressed as means ±
SD. The Shapiro-Wilk test was used to assess the normality
of the variable distributions. One-way ANOVA followed
by Bonferroni’s post hoc test was adopted for comparisons
among selected pairs of groups: Control Sham versus Control
IR; Control Sham versus HFHF Sham; Control IR versus
HFHF IR; HFHF Sham versus HFHF IR. A 𝑃 value <
0.05 was considered statistically significant. Statistical tests
were performed with GraphPad Prism 6.0 software package
(GraphPad Software, San Diego, CA, USA).
3. Results
3.1. General Parameters. After 12 weeks of HFHF diet, mice
showed amarked increase in total body weight, accompanied
by reduced heart-to-body weight ratio and a significant
increase in plasma fasting levels of glucose, insulin, triglyc-
erides, and cholesterol, when compared to Control mice
(Table 1). In contrast, HFHF diet did not affect systolic blood
pressure or pulse rate (data not shown).
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Table 1: General parameters of mice after 12 weeks of Control or
high-fat high-fructose (HFHF) diets.
Control
(𝑛 = 10)
HFHF
(𝑛 = 12)
Body weight increase
(g) 8.5 ± 1.6 14.7 ± 3.2
∗∗∗
Heart weight
(% of body w.) 0.45 ± 0.02 0.35 ± 0.06
∗∗
Plasma glucose
(mg/dL) 73 ± 19 139 ± 13
∗∗∗
Plasma insulin
(mg/mL) 85.8 ± 5.3 106.8 ± 6.8
∗∗∗
Plasma TG
(mg/dL) 32.8 ± 7.8 66.5 ± 25.5
∗∗∗
Plasma Chol.
(mg/dL) 77.2 ± 5.7 97.2 ± 8.2
∗∗
Data are means ± SD. ∗∗𝑃 < 0.01, ∗∗∗𝑃 < 0.005 versus Control.
3.2. Diet-Induced Cardiac Adaptation. As a shift in myosin
heavy chain (MHC) isoform content from 𝛼 to 𝛽 is known to
contribute to the development of heart failure, we measured
the cardiac expression of the two functionally distinct cardiac
MHC isoforms by western blotting analysis. As shown in
Figure 1(a), a marked increase in 𝛽-MHC expression par-
alleled by a slight reduction in expression of 𝛼-MHC was
recorded in the hearts of mice chronically exposed to the
HFHF diet in comparison to hearts from Control mice,
thus confirming a significant MHC isoform shift. This effect
was associated with dramatic increase of CPT-1m and SDH,
two markers of oxidative metabolism, following HFHF diet
exposure (Figure 1(b)).
In addition, Oil RedO staining on heart sections revealed
an intramyocellular lipid accumulation in HFHF mice that
was not detected in Control mice (Figure 1(c)).
3.3. Infarct Area and LDH Release Increased in HFHF Hearts.
When mice underwent myocardial IR, the IR infarct size
recorded in the HFHF group was doubled with respect to
that recorded in the Control IR (Figure 2(a)). Total LDH
release during the 60 min of reperfusion corroborated this
observation as it reached a 2.5-fold increase in HFHF IR
group when compared to the Control IR value (Figure 2(b)).
3.4. Effects of HFHF and IR Injury on Cardiac GLUT-4 Trans-
location and Expression and IRS-2 Activation. Immuno-
histochemistry and western blotting analysis showed that
translocation from cytosol to membranes (Figure 3(a)) and
expression (Figure 3(b)) of GLUT-4 were both reduced by
HFHF diet, thus indicating a diet-induced insulin resistance
of the cardiomyocytes. This was confirmed by the markedly
increased phosphorylation rate of IRS-2 that inactivates
insulin signaling inHFHF hearts assessed bywestern blotting
(Figure 3(c)). The IR challenge induced the increase in
GLUT-4 translocation and IRS-2 activation in Control mice,
while in HFHF-fed mice IR did not significantly modify
GLUT-4 expression and translocation or IRS-2 phosphory-
lation rate, with respect to HFHF Sham (Figures 3(a), 3(b),
and 3(c)).
3.5. Effects of HFHF and IR Injury on Cardiac Lipid Per-
oxidation and Mitochondrial Oxidative Stress. As shown by
western blotting analysis, HFHF diet induced a significant
increase in HNE-protein adducts in both Sham and IR
experimental conditions in comparison to Controlmice, thus
demonstrating a robust diet-induced production of lipid per-
oxidation products (Figure 4(a)). Interestingly, hearts expo-
sure to the IR challenge evoked a further increase in the levels
of lipid peroxidation products in both Control and HFHF
groups (Figure 4(a)). When the expression of the antioxidant
MnSOD enzyme was measured, a significant upregulation
was recorded following chronic treatment withHFHFdiet. In
contrast, IR injury induced MnSOD expression in the heart
of Control mice but not in the heart of HFHF mice, thus
suggesting that the antioxidant defense inHFHF hearts could
not be further increased by IR (Figure 4(b)).
3.6. NLRP3 Inflammasome Complex Activation. As assessed
by western blot analysis, IR induced a strong upregulation
of both Nlrp3 inflammasome and activated caspase-1 in the
heart samples from Control and HFHF mouse, although
basal expression levels of Nlrp3 inflammasome and activated
caspase-1 in Sham HFHF mouse hearts were already dras-
tically higher than those recorded in Sham Control hearts
(Figure 5).
3.7. RISK Pathway Activation. In Control diet hearts, IR
challenging did not induce significant variations of phospho-
ERK1/2 (Figure 6(a)), while a marked increase in both
phospho-Akt/Akt (Figure 6(b)) and phospho-GSK-3𝛽/GSK-
3𝛽 ratios (Figure 6(c)) was observed. The basal levels of
ERK1/2, Akt, and GSK-3𝛽 phosphorylation in the hearts of
the HFHF group were significantly lower than those reported
in the Control diet hearts. The IR-induced upregulation
of enzyme phosphorylation following dietary manipulation
still remained lower than those evoked by the same insult
in Control mice and no effects were recorded on ERK1/2
expression and phosphorylation.
3.8. HIF-2𝛼 Activation. Twelve weeks of HFHF diet led to
a slight but not significant reduction in HIF-2𝛼 expression
in heart extracts. Hearts from Control mice exposed to
IR underwent a robust induction of HIF-2𝛼 expression. In
contrast, in the hearts of HFHF mice, the expression level
of HIF-2𝛼 was reduced by HFHF exposure and reported to
Control Sham value by IR, remaining significantly lower than
in IR Control hearts (Figure 7).
4. Discussion
In this study, we demonstrated that chronic feeding with
an HFHF diet induces a maladaptive response in cardiac
tissue, as shown by the 𝛼- to 𝛽-MHC isoform shift, the
increased expression of markers of mitochondrial oxidative
metabolism, such as CPT-1m and SDH, and the reduced
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Figure 1: Cardiac metabolic adaptations to diet. Representative western blotting showing cardiac levels of 𝛼-MHC and 𝛽-MHC isoforms
(a) and of markers of oxidative metabolism CPT-1 and SDH (b) assessed after 12 weeks of Control or HFHF diet in heart apex extracts.
Histograms report densitometric analysis of 10–12 mice per group normalized for the corresponding tubulin content. ∗𝑃 < 0.05 versus
Control. (c) Representative 20x/40xmagnification photomicrographs of heart apex sections fromControl orHFHF dietmice showing cardiac
intramyocellular lipid accumulation by Oil Red O staining.
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Figure 2: Infarct area and LDH release. Hearts from mice fed for 12 weeks with Control or HFHF diet, exposed to 30-minute ischemia plus
60-minute reperfusion. (a) Infarct size in the basal part of the ventricle after IR exposition is expressed as a percentage of ischemic tissue
(%IS/IT). (b) LDH release in the perfusion effluent during the IR was expressed as units per mg of wet tissue weight. ∗𝑃 < 0.05 versus
Control.
cardiac glucose uptake. Interestingly, despite increasedmark-
ers of oxidative metabolism, HFHF diet was associated
with intramyocytes triglyceride accumulation, suggesting
that the tightly regulated process of FA uptake and utilization
was perturbed. These effects were paralleled by a robust
increase in markers of mitochondrial oxidative stress and
lipid peroxidation in the hearts of HFHFmice. Similar results
have been previously documented in different experimental
models of diabetic cardiomyopathy [24, 25] and the effect of
myocardial lipid accumulation on the impairment of systolic
cardiac performance is well known [26]. Although there are
contrasting data on cardiac postischemic outcomes inmodels
of diet-induced dysmetabolism [27], we here documented
worsening of cardiac IR effects in animals exposed to the
obesogenic/diabetogenic diet. To better elucidate the impact
of dietary manipulation on myocardial IR injury, we assessed
the expression and activation of IR-related signaling path-
ways. One of the most widely studied protective cascades
which is involved in mediating the protective effects of many
cardioprotective interventions is the RISK pathway [16, 28,
29]. Interestingly, the activities of members of the RISK path-
way, including Akt, ERK1/2, and GSK-3𝛽, are often impaired
in conditions of diabetes, obesity, insulin resistance, and
hypercholesterolemia [3, 16, 29, 30]. In this context, we previ-
ously reported that high-fat high sugar diets lead to reduced
Akt-mediated insulin signaling [21, 31]. Here we show that
the protective myocardial RISK pathway is upregulated by
cardiac IR challenging and, most notably, this upregulation
is lost in HFHF mice. These results suggest that the reduced
RISK activation contributes to the exacerbated myocardial
injury inHFHFmice.This is consistent with findings of other
authors showing that the presence ofmetabolic derangements
abrogates the protective preconditioning-induced activation
of RISK pathway [16, 30, 32]. A consequence of the RISK
pathway activation in the early response to cardiac oxygen
deprivation is the increased expression of HIF-2𝛼 in remote
areas from the infarct [18]. HIF-2𝛼 regulates key processes
of long-term adaptation andmaintains mitochondrial home-
ostasis by regulating production of antioxidant enzymes [33].
A recent research study reported the association between
reduced Akt signaling and impaired HIF proteins activity
[34]. Moreover, recent studies indicate that HIF-2𝛼 directly
regulates IRS-2 transcription in diabetic mice both in vivo
and in primary hepatocytes, thus improving insulin sensitiv-
ity and increasing Akt activation [35, 36]. Our results further
extend this observation, demonstrating for the first time that
an HFHF diet negatively impacts cardiac HIF-2𝛼 expression
during IR, thus compromising the heart response to IR and
the related activation of the insulin signalling.
Intriguingly, the diet-induced inhibition of protective
signaling pathways was associated with a robust increase
in myocardial protein levels of Nlrp3 inflammasome. The
key role of the Nlrp3 inflammasome as central mediator
in the inflammatory response to tissue injury during either
myocardial infarction or insulin resistance is already known
[7, 37, 38]. Strong correlations between the expression of
Nlrp3 inflammasome-related genes and insulin resistance
have been recently reported in obese male subjects with
impaired glucose tolerance and in type 2 diabetic patients
[39, 40]. Besides, genetic or pharmacological inhibition of
Nlrp3 inflammasome reduces infarct size and limits the
development of diet-induced obesity [41, 42]. However, the
present study is, to the best of our knowledge, the first
one demonstrating that the upregulation of Nlrp3 protein
evoked by IR injury is drastically higher in the presence
of a diet-induced metabolic derangement. These findings
suggest a potential association between increased activity
of Nlrp3 inflammasome following metabolic derangements
and enhanced susceptibility to a myocardial ischemic insult.
Overall, the diet- and IR-induced redox imbalance may
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Figure 3: Localization and expression of GLUT-4 and IRS-2 activation in the mouse heart. Representative 40x magnification photomi-
crographs of heart apex sections and western blotting analysis on heart apex extracts from Control or HFHF diet mice, exposed or not
to IR, showing GLUT-4 localization (a) and expression (b). Representative western blotting for cardiac levels of total IRS-2 and Ser270
phosphorylation performedonheart apex extracts fromControl orHFHFdietmice, exposed or not to IR (c).Histogram reports densitometric
analysis of the phosphorylated-to-total form ratio of 5-6 mice per group. ∗𝑃 < 0.05 versus Control; ∙𝑃 < 0.05 versus Sham.
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Figure 4: Oxidative stress parameters. Representative western blotting showing cardiac levels of HNE-protein adducts (a) and MnSOD (b)
assessed on heart apex extracts from Control or HFHF diet mice, with or without IR. Histograms report densitometric analysis of 5-6 mice
per group normalized, respectively, for the corresponding tubulin content. ∗𝑃 < 0.05 versus Control; ∙𝑃 < 0.05 versus Sham.
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Figure 5: Inflammasome expression and activation in the mouse heart. Representative western blotting showing cardiac levels of Nlrp3 (a),
the best characterized element of inflammasome complex, and of downstream activation of caspase-1 (b) assessed on heart apex extracts from
Control or HFHF diet mice, with or without IR. Histograms report densitometric analysis of 5-6 mice per group normalized, respectively, for
the corresponding tubulin content or the procaspase-1 content. ∗𝑃 < 0.05 versus Control; ∙𝑃 < 0.05 versus Sham.
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Figure 6: Prosurvival RISK pathway activation in the mouse heart. Representative western blotting for cardiac levels of total ERK1/2
expression and Thr202/Tyr204 phosphorylation, respectively, (a), total Akt protein expression and Ser473 phosphorylation (b), and total
GSK-3 protein expression and Ser9 phosphorylation (c) performed on heart apex extracts from Control or HFHF diet mice, exposed or not
to IR. Histograms report densitometric analysis of the phosphorylated-to-total form ratio of 5-6 mice per group. ∗𝑃 < 0.05 versus Control;
∙
𝑃 < 0.05 versus Sham.
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Figure 7: HIF-2𝛼 expression in the mouse heart. Representative western blotting for cardiac levels of HIF-2𝛼 performed on heart apex
extracts from Control or HFHF diet mice, exposed or not to IR. Histograms report densitometric analysis of 5-6 mice per group normalized
for the corresponding tubulin content. ∗𝑃 < 0.05 versus Control; ∙𝑃 < 0.05 versus Sham.
represent the key event leading to the signaling pathways
modifications. Indeed, a previous study showed that HIF-
2𝛼 knockout mice show multiorgan damage due to ROS
overproduction [43], and genetic deletion of HIF-2𝛼 resulted
in increased levels of oxidative stress markers [33]. In keeping
with these findings, we observed a reduced expression ofHIF-
2𝛼 and MnSOD in HFHF mice exposed to IR, which could
account for the dramatic increase in HNE-adducts. Similarly,
mitochondrial oxidative stress is one of the main stimuli
triggering Nlrp3 activation [44–46]. For instance, HNE
treatment of retinal pigment epithelial cells strongly induces
Nlrp3 expression, leading to IL-1𝛽 and IL-18 production
[47]. We may, thus, speculate that the oxidative unbalance
due to impairments in RISK/HIF-2𝛼 pathways can worsen
the proinflammatory response triggered by Nlrp3 activation.
However, further investigations are required to better eluci-
date the intricate mechanisms of cross-talk among signaling
pathways operational in the pathogenesis and potentially also
the resolution of CMDs.
The experimental model here proposed allows us to
study the intrinsic capacity of the myocardium to afford the
IR challenge in a strictly controlled environment, avoiding
extracardiac influences and the possible effect of temperature
and collateral flow variations. However, we are aware of some
limitations of the present study, including the lack of hemo-
dynamic and functional data of postischemic myocardium
and the impossibility to dissect between the redox effects on
postischemic necrosis and stunning. Future ad hoc studies,
with implemented technologies, are required to clarify these
aspects.
In conclusion, our results clearly demonstrate that a
high-fat high-fructose diet alters different signaling pathways
involved in cardiac IR injury. While elements of cardiopro-
tective pathways are downregulated, those of inflammatory
processes are upregulated byHFHFdiet and IR injury is exac-
erbated by these maladaptive pathway modulations. These
results offer further improvements of our understanding of
the link between cardiovascular andmetabolic injuries. How-
ever, further studies are needed to better clarify the reciprocal
interaction of these pathways within CMDs pathogenesis,
thus allowing the identification of new therapeutic targets for
improving postischemic recovery in obese/diabetic patients.
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